TR200400313T3 - Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler - Google Patents

Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler

Info

Publication number
TR200400313T3
TR200400313T3 TR200400313T TR200400313T TR200400313T3 TR 200400313 T3 TR200400313 T3 TR 200400313T3 TR 200400313 T TR200400313 T TR 200400313T TR 200400313 T TR200400313 T TR 200400313T TR 200400313 T3 TR200400313 T3 TR 200400313T3
Authority
TR
Turkey
Prior art keywords
forms
oxcarbazepine
processes
preparation
new crystal
Prior art date
Application number
TR200400313T
Other languages
English (en)
Turkish (tr)
Inventor
Judith Aronhime
Ben-Zion Dolitzky
Yana Berkovich
Nissim Garth
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of TR200400313T3 publication Critical patent/TR200400313T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR200400313T 2001-02-12 2002-02-12 Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler TR200400313T3 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26831401P 2001-02-12 2001-02-12

Publications (1)

Publication Number Publication Date
TR200400313T3 true TR200400313T3 (tr) 2004-04-21

Family

ID=23022405

Family Applications (1)

Application Number Title Priority Date Filing Date
TR200400313T TR200400313T3 (tr) 2001-02-12 2002-02-12 Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler

Country Status (11)

Country Link
US (1) US7183272B2 (https=)
EP (1) EP1368322A4 (https=)
JP (1) JP2004526706A (https=)
AU (1) AU2002250057A1 (https=)
CA (1) CA2437402A1 (https=)
DE (1) DE02718948T1 (https=)
ES (1) ES2211373T1 (https=)
HU (1) HUP0303154A3 (https=)
IL (1) IL157351A0 (https=)
TR (1) TR200400313T3 (https=)
WO (1) WO2002064557A2 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7091339B2 (en) 2002-06-14 2006-08-15 Taro Pharmaceuticals Usa, Inc. Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide
GB0223224D0 (en) * 2002-10-07 2002-11-13 Novartis Ag Organic compounds
US20060166968A1 (en) * 2004-07-16 2006-07-27 Sundaram Venkataraman Crystalline form of oxcarbazepine
US7563930B2 (en) * 2005-11-22 2009-07-21 Teva Pharmaceutical Industries Ltd Crystal forms of Cinacalcet HCI and processes for their preparation
EP2662374A1 (en) * 2006-04-05 2013-11-13 OPKO Health, Inc. Salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl]-8-phenyl-1,7 -diaza-spiro[4.5]decan-2-one and preparation process therefor
ES2360423T3 (es) 2006-04-26 2011-06-03 Supernus Pharmaceuticals, Inc. Preparaciones de liberación controlada de oxcarbazepina que tienen perfil de liberación sigmoidal.
ITMI20062449A1 (it) * 2006-12-19 2008-06-20 Dipharma Spa Forma cristallina di rabeprazolo sodico
ITMI20071502A1 (it) * 2007-07-25 2009-01-26 Archimica Srl Procedimento per la preparazione di formulazioni solide a rilascio controllato contenenti oxcarbazepina e formulazioni ottenibili con tale procedimento
CN102573475B (zh) * 2009-08-14 2016-01-20 欧科生医股份有限公司 神经激肽-1拮抗剂的静脉内制剂
WO2011071853A2 (en) 2009-12-07 2011-06-16 Academic Pharmaceuticals Incorporated Parenteral formulation of clopidogrel
AR099354A1 (es) 2013-11-15 2016-07-20 Akebia Therapeutics Inc Formas sólidas de ácido {[5-(3-clorofenil)-3-hidroxipiridin-2-carbonil]amino}acético, composiciones, y sus usos
BR112021005955A2 (pt) 2018-09-28 2021-07-27 Griffith University agentes e métodos para modular atividade de patógeno

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH500196A (de) * 1969-03-10 1970-12-15 Ciba Geigy Ag Verfahren zur Herstellung von neuen Azepinderivaten
FI75561C (fi) * 1979-10-30 1988-07-11 Ciba Geigy Ag Foerfarande foer framstaellning av 5- karbamoyl-10-oxo-10,11-dihydro-5h-dibens/b,f/azepin och daertill noedvaendiga mellanprodukter.
FR2700117B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Application d'anticonvulsivants dans le traitement de la maladie de Parkinson et des syndromes parkinsoniens.
IT1272897B (it) * 1995-01-13 1997-07-01 I F C Iniziative Finanziaarie Processo per la produzione di 10-oxo-10,11-diidro-sh- -dibenz(b,f) azepin-5-carbossiammide
US6670472B2 (en) * 2001-10-09 2003-12-30 Max India Limited Process for the preparation of 10-methoxycarbamazepine
US7091339B2 (en) 2002-06-14 2006-08-15 Taro Pharmaceuticals Usa, Inc. Method of preparing a 5H-dibenz(b,f)azepine-5-carboxamide

Also Published As

Publication number Publication date
DE02718948T1 (de) 2004-07-08
EP1368322A2 (en) 2003-12-10
HUP0303154A3 (en) 2009-08-28
WO2002064557A3 (en) 2002-10-24
ES2211373T1 (es) 2004-07-16
US20030004154A1 (en) 2003-01-02
IL157351A0 (en) 2004-02-19
US7183272B2 (en) 2007-02-27
CA2437402A1 (en) 2002-08-22
WO2002064557A9 (en) 2002-11-28
AU2002250057A1 (en) 2002-08-28
WO2002064557A2 (en) 2002-08-22
JP2004526706A (ja) 2004-09-02
EP1368322A4 (en) 2004-03-17
HUP0303154A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
NO20035177D0 (no) Krystallformer av Azithromycin
ID28779A (id) BENTUK-BENTUK KRISTAL DARI EtO2C-CH2-(R)CgL-Aze-Pab-OH
ID25534A (id) Glucagon-seperti kristal peptida-1
DE60227301D1 (de) Strukturen von anschlusselementen und anzuschliessende komponente
DE60223735D1 (de) Interferometer und zugehöriges Herstellungsverfahren
TR200400313T3 (tr) Okskarbazepinin yeni kristal biçimleri ve bu biçimlerin hazirlanmasi için islemler
DE60221847D1 (de) Schlaufenmaterialien für klettverschlüsse
NO20022087L (no) Fremgangsmåte for behandling av diabetes
DE50212455D1 (de) Verwendung von Dimerdiolen
NO983632L (no) Krystallform av N-(4-trifluormetylfenyl)-5-metyl-isoksazol-4-karboksamid
DE60135932D1 (de) Farbumsetzeinrichtung und farbumsetzverfahren
DK1399424T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
NO20041850L (no) Fremgangsmate for dannelse av profenkrystaller
DE50003755D1 (de) Satz von schmuckstücken
ID21014A (id) Modifikasi kristal dari zat farmasi
IL157608A0 (en) New crystal forms of lamotrigine and processes for their preparations
NO20023445L (no) Fremgangsmåte for fremstilling av peptider
NO20042613L (no) Ny anvendelse for behandling av gastroosofagial refluks
DK1102747T3 (da) Krystalformer af osenetant
NO20040346L (no) Ny krystall av aryletensulfonamid-derivat og fremstillingsprosess derav
DE60132986D1 (de) Verbindungen und methoden zur senkung des cholesterinspiegels ohne induktion von hypertriglyceridämie
NO995300D0 (no) Anvendelse av 1-ar(alk)yl-imidazolin-2-on for behandling av angst- og spenningstilstander
NO20031045L (no) Ny polymorf form av 17-<beta>-(N-tert.butylkarbamoyl)-4-aza-5- <alfa>-ANDROST-1-en-3-on og en fremgangsmåte for fremstilling av samme
DE50115118D1 (de) Mikromechanisches bauelement und abgleichverfahren
EP1272845A4 (en) SOLUTION AND CRYSTALLINE STRUCTURES OF ZIPA AND ZIPA COMPLEX AND THEIR USES